Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 52 (RPL7P52)

Target: RPL7P52
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L7 pseudogene 52 (RPL7P52) is a human processed pseudogene that is homologous to the functional ribosomal protein L7 gene but does not encode a protein. Like many ribosomal protein pseudogenes, RPL7P52 is the result of gene duplication or retrotransposition events and is not transcribed or translated into a functional product. There is no evidence that RPL7P52 has any biological activity, involvement in disease, or interaction with drugs. It is primarily noted in genomic studies as a nonfunctional remnant associated with the ribosomal protein gene family[1][2][5][7][11].

Other names: RPL7_21_1751RPL7P52

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 52 (RPL7P52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 52 (RPL7P52).

Explore the full profile